Literature DB >> 21195595

Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery.

Roop Kaw1, Vinay Pasupuleti, Abhishek Deshpande, Tarek Hamieh, Esteban Walker, Omar A Minai.   

Abstract

OBJECTIVES: Perioperative risk associated with pulmonary hypertension (PH) in patients undergoing non-cardiac surgery (NCS) remains poorly defined. We report perioperative outcomes in a large cohort of patients undergoing NCS, comparing those with and without PH.
METHODS: Patients undergoing NCS at our institution between January 2002 and December 2006, were cross matched with a Right Heart Catheterization (RHC) database for the same period. Patients were excluded if they were <18 years old and if they underwent cardiac surgery prior to NCS or minor procedures using local anesthesia or sedation. Controls were defined as patients who underwent similar NCS with mean pulmonary arterial pressure (MPAP) ≤ 25 mmHg.
RESULTS: 173 patients underwent RHC and NCS during the specified period and were included in the analysis. Of these 96 (55%) had PH. Mean pulmonary arterial pressure (p = 0.001), American Association of Anesthesiology Class (p = 0.02), and chronic renal insufficiency (p = 0.03) were determined as independent risk factors for post-operative morbidity. Patients with PH were more likely to develop congestive heart failure (p < 0.001; OR: 11.9), hemodynamic instability (p < 0.002), sepsis (p < 0.0005), and respiratory failure (p < 0.004). Patients with PH needed longer ventilatory support (p < 0.002), stayed longer in the ICU (p < 0.04), and were more frequently readmitted to the hospital within 30 days (p < 008; OR 2.4).
CONCLUSIONS: In addition to the traditionally known risk factors for outcomes after NCS such as coronary artery disease, diabetes mellitus, chronic renal insufficiency, American Society of Anesthesiology class, the presence of underlying PH can have a significant negative impact on perioperative outcomes.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21195595     DOI: 10.1016/j.rmed.2010.12.006

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  49 in total

Review 1.  [Management of patients with pulmonary hypertension].

Authors:  B Preckel; S Eberl; J Fräßdorf; M W Hollmann
Journal:  Anaesthesist       Date:  2012-07       Impact factor: 1.041

2.  [Blind in the right eye? : Perioperative management of high risk cardiac patients].

Authors:  S Rex
Journal:  Anaesthesist       Date:  2012-07       Impact factor: 1.041

3.  The effect of pulmonary hypertension on inpatient outcomes of laparoscopic procedures.

Authors:  Loka Thangamathesvaran; Sarah J Armenia; Aziz M Merchant
Journal:  Updates Surg       Date:  2018-06-27

4.  Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension.

Authors:  Ralf Ewert; Manuel J Richter; Regina Steringer-Mascherbauer; Ekkehard Grünig; Tobias J Lange; Christian F Opitz; Christian Warnke; Hossein-Ardeschir Ghofrani
Journal:  Clin Res Cardiol       Date:  2017-04-20       Impact factor: 5.460

5.  Clinical outcomes in patients with pulmonary hypertension undergoing total hip arthroplasty.

Authors:  David Kim; Kethy Jules-Elysee; Lauren Turteltaub; Michael K Urban; Jacques T YaDeau; Shane Reid; Stephen Lyman; Yan Ma
Journal:  HSS J       Date:  2014-05-03

Review 6.  Current clinical management of pulmonary arterial hypertension.

Authors:  Roham T Zamanian; Kristina T Kudelko; Yon K Sung; Vinicio de Jesus Perez; Juliana Liu; Edda Spiekerkoetter
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 7.  Post-operative outcomes in adult obstructive sleep apnea patients undergoing non-upper airway surgery: a systematic review and meta-analysis.

Authors:  Swarna Gaddam; Sameer K Gunukula; M Jeffery Mador
Journal:  Sleep Breath       Date:  2013-12-12       Impact factor: 2.816

Review 8.  Perioperative management of patients with pulmonary hypertension for non-cardiac surgery.

Authors:  Elaine I Yang
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

9.  Cardiovascular Outcomes of Patients With Pulmonary Hypertension Undergoing Noncardiac Surgery.

Authors:  Nathaniel R Smilowitz; Andrew Armanious; Sripal Bangalore; Harish Ramakrishna; Jeffrey S Berger
Journal:  Am J Cardiol       Date:  2019-02-08       Impact factor: 2.778

10.  Selective endothelin-A receptor blockade attenuates endotoxin-induced pulmonary hypertension and pulmonary vascular dysfunction.

Authors:  Brent M Toney; Amanda J Fisher; Marjorie Albrecht; Angelia D Lockett; Robert G Presson; Irina Petrache; Tim Lahm
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.